This happens because your hunger levels return to what they were before the medication
Retatrutide (LY-3437943) is an investigational triple agonist activating: GLP-1 receptors GIP receptors Glucagon receptors This triple-pathway mechanism has produced some of the largest average weight-loss outcomes reported in obesity trials , positioning retatrutide as one of the most potent investigational metabolic agents to date
For example, the schedule could progress to 2 mg, then to 4 mg, 6 mg, 8 mg, 10 mg, and potentially 12 mg per week
In response to this crisis, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a groundbreaking class of medications for weight management
If you check your own blood sugar at home, log readings for 24 weeks before starting to document your current hypoglycemia patterns and frequency
I mean, great for them